Literature DB >> 6629117

Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.

I V Weller, P Karayiannis, A S Lok, L Montano, M Bamber, H C Thomas, S Sherlock.   

Abstract

Delta antigen (delta) is a transmissible agent requiring hepatitis B virus (HBV) for its replication. Antibody to delta (anti-delta) was present in nine of 71 (13%) British HBV carriers: six were intravenous drug abusers and two were haemophiliacs. Anti-delta was negative in 30 HBsAg positive homosexuals. Cirrhosis was common in patients with anti-delta and those with anti-delta positive cirrhosis were significantly younger than those with anti-delta negative cirrhosis. In British HBV carriers delta infection is associated with intravenous drug abuse and haemophilia and perhaps a more rapid progression of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6629117      PMCID: PMC1420126          DOI: 10.1136/gut.24.11.1061

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

2.  Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders.

Authors:  M Bamber; A Murray; B A Arborgh; P J Scheuer; P B Kernoff; H C Thomas; S Sherlock
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

3.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

4.  The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier.

Authors:  F Bonino; B Hoyer; E Ford; J W Shih; R H Purcell; J L Gerin
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

5.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen.

Authors:  M Rizzetto; J W Shih; J L Gerin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection.

Authors:  E Stöcklin; F Gudat; G Krey; U Dürmüller; M Gasser; M Schmid; G Stalder; L Bianchi
Journal:  Hepatology       Date:  1981 May-Jun       Impact factor: 17.425

8.  Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention.

Authors:  R G Knodell; M E Conrad; K G Ishak
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

9.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

10.  Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.

Authors:  M Rizzetto; C Morello; P M Mannucci; D J Gocke; J A Spero; J H Lewis; D H Van Thiel; C Scaroni; F Peyretti
Journal:  J Infect Dis       Date:  1982-01       Impact factor: 5.226

View more
  20 in total

Review 1.  Sexually transmitted hepatitis: a review.

Authors:  R J Gilson
Journal:  Genitourin Med       Date:  1992-04

2.  Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

Authors:  I V Weller; A S Lok; A Mindel; P Karayiannis; S Galpin; J Monjardino; S Sherlock; H C Thomas
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

3.  Delta infection in eastern Sicily.

Authors:  A Smedile; M A Freni; L Caruso; A Ajello; C Trischitta; M L Resta; G Bertino; G Berlinghieri; S Rapisarda; L Di Geronimo
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

Review 4.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

5.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

Review 6.  Natural history of the HBsAg carrier.

Authors:  M G Anderson; I M Murray-Lyon
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

7.  The delta agent comes of age.

Authors:  H C Thomas
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

8.  Re: S. Iwarson: new vaccines against hepatitis A enter the market--but who should be vaccinated? (Infection 20 [1992] 192-193)

Authors:  R Orlando; G Tosone; S Nappa; M Piazza
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  Antiviral treatment of chronic hepatitis B virus infection.

Authors:  D M Novick; H C Thomas
Journal:  J R Soc Med       Date:  1984-12       Impact factor: 5.344

Review 10.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.